Acute Liver Failure와 Acute-on-chronic Liver Failure에서 임상양상의 차이

The Difference of the Clinical Patterns between Acute Liver Failure and Acute-on-Chronic Liver Failure

  • 최종영 (가톨릭대학교 의과대학 내과 서울성모병원 간이식 클리닉)
  • 발행 : 2009.03.25

초록

키워드

참고문헌

  1. Ritt DJ, Whelan G, Werner DJ, Eigenbrodt EH, Schenker S, Combes B. Acute hepatic necrosis with stupor or coma. An analysis of thirty-one patients. Medicine (Baltimore) 1969;48:151-72. https://doi.org/10.1097/00005792-196903000-00003
  2. Trey C, Davidson CS. The management of fulminant hepatic failure. Prog Liver Dis 1970;3:282-98.
  3. Polson J, Lee WM. AASLD position paper: the management of acute liver failure. Hepatology 2005;41:1179-97. https://doi.org/10.1002/hep.20703
  4. Ostapowicz G, Fontana RJ, Schiodt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002;137:947-54. https://doi.org/10.7326/0003-4819-137-12-200212170-00007
  5. Higgins PD, Fontana RJ. Liver transplantation in acute liver failure. Panminerva Med 2003;45:85-94.
  6. O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989;97:439-45.
  7. Shakil AO, Kramer D, Mazariegos GV, Fung JJ, Rakela J. Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl 2000;6:163-9.
  8. Anand AC, Nightingale P, Neuberger JM. Early indicators of prognosis in fulminant hepatic failure: an assessment of the King's criteria. J Hepatol 1997;26:62-8. https://doi.org/10.1016/S0168-8278(97)80010-4
  9. Bernal W, Donaldson N, Wyncoll D, Wendon J. Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: a cohort study. Lancet 2002;359:558-63. https://doi.org/10.1016/S0140-6736(02)07743-7
  10. Izumi S, Langley PG, Wendon J, et al. Coagulation factor V levels as a prognostic indicator in fulminant hepatic failure. Hepatology 1996;23:1507-11. https://doi.org/10.1002/hep.510230630
  11. Jalan R, Williams R. Acute-on-chronic liver failure: pathophysiological basis of therapeutic options. Blood Purif 2002;20:252-61. https://doi.org/10.1159/000047017
  12. Wendon JA, Harrison PM, Keays R, Gimson AE, Alexander GJ, Williams R. Effects of vasopressor agents and epoprostenol on systemic hemodynamics and oxygen transport in fulminant hepatic failure. Hepatology 1992;15:1067-71. https://doi.org/10.1002/hep.1840150616
  13. Clemmesen JO, Galatius S, Skak C, Dalgaard P, Larsen FS, Ott P. The effect of increasing blood pressure with dopamine on systemic, splanchnic, and lower extremity hemodynamics in patients with acute liver failure. Scand J Gastroenterol 1999;34:921-7. https://doi.org/10.1080/003655299750025417
  14. Davenport A, Will EJ, Davidson AM. Improved cardiovascular stability during continuous modes of renal replacement therapy in critically ill patients with acute hepatic and renal failure. Crit Care Med 1993;21:328-38. https://doi.org/10.1097/00003246-199303000-00007
  15. Rolando N, Harvey F, Brahm J, et al. Prospective study of bacterial infection in acute liver failure: an analysis of fifty patients. Hepatology 1990;11:49-53. https://doi.org/10.1002/hep.1840110110
  16. Rolando N, Harvey F, Brahm J, et al. Fungal infection: a common, unrecognised complication of acute liver failure. J Hepatol 1991;12:1-9. https://doi.org/10.1016/0168-8278(91)90900-V
  17. Rolando N, Gimson A, Wade J, Philpott-Howard J, Casewell M, Williams R. Prospective controlled trial of selective parenteral and enteral antimicrobial regimen in fulminant liver failure. Hepatology 1993;17:196-201. https://doi.org/10.1002/hep.1840170206
  18. Vaquero J, Polson J, Chung C, et al. Infection and the progression of hepatic encephalopathy in acute liver failure. Gastroenterology 2003;125:755-64. https://doi.org/10.1016/S0016-5085(03)01051-5
  19. Lee WM, Squires RH, Jr., Nyberg SL, Doo E, Hoofnagle JH. Acute liver failure: Summary of a workshop. Hepatology 2008;47:1401-15. https://doi.org/10.1002/hep.22177
  20. Park SJ, Lim YS, Lee WJ, et al. Prospective analysis of etiologies and outcomes of fulminant hepatic failure in Korea - single institution analysis. Korean J Hepat 2007;3S:28.
  21. Blei AT. Brain edema in acute liver failure: can it be prevented? Can it be treated? J Hepatol 2007;46:564-9. https://doi.org/10.1016/j.jhep.2007.01.011
  22. Verma A, Saraswat VA, Radha Krishna Y, Nath K, Thomas MA, Gupta RK. In vivo 1H magnetic resonance spectroscopy-derived metabolite variations between acute-on-chronic liver failure and acute liver failure. Liver Int 2008;28:1095-103. https://doi.org/10.1111/j.1478-3231.2007.01648.x
  23. Rai V, Nath K, Saraswat VA, Purwar A, Rathore RK, Gupta RK. Measurement of cytotoxic and interstitial components of cerebral edema in acute hepatic failure by diffusion tensor imaging. J Magn Reson Imaging 2008;28:334-41. https://doi.org/10.1002/jmri.21438
  24. Lee HC. Acute liver failure related to hepatitis B virus. Hepatol Res 2008;38:S9-S13. https://doi.org/10.1111/j.1872-034X.2008.00420.x
  25. 2005 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry for Transplant Recipients: Transplant Data 1995-2004: Department of Health and Human Services, Health Resources and Services Administration, Office of Special Programs, Division of Transplantation, Rockville, MD; United Network for Organ Sharing, Richmond, VA; University Renal Research and Education Association, Ann Arbor, MI, 2006.